Article Text
PDFDTB select
Risk of DKA with SGLT2 inhibitors
Abstract
Every month, DTB scans sources of information on treatments, disease management and other healthcare topics for key items to bring to our readers’ attention and help them keep up to date. To do this, we produce succinct, contextualised summaries of the information concerned.
- Health Care Quality
- Access
- and Evaluation
- Drug-Related Side Effects and Adverse Reactions
Statistics from Altmetric.com
Request Permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information:
© BMJ Publishing Group Limited 2021. No commercial re-use. See rights and permissions. Published by BMJ.